Del Laboratories Income Statement
View: Annual
| Dec 08#* | Dec 05 | Dec 04* | |
|---|---|---|---|
| Revenue | 0.0 | 397.6 | 395.2 |
| Cost of Goods Sold | 242.4 | 220.7 | 198.4 |
| Gross Profit | (242.4) | 176.8 | 196.7 |
| Gross Profit Margin | 0.0% | 44.5% | 49.8% |
| SG&A Expense | 177.9 | 197.0 | 168.5 |
| Depreciation & Amortization | 15.7 | 12.5 | 8.5 |
| Operating Income | 5.7 | (20.1) | 28.2 |
| Operating Margin | -- | -- | 7.1% |
| Nonoperating Income | 0.4 | 1.1 | 0.3 |
| Nonoperating Expenses | 37.1 | 34.6 | 3.7 |
| Income Before Taxes | (31.1) | (53.7) | 24.8 |
| Income Taxes | (11.4) | (39.8) | 10.2 |
| Net Income After Taxes | (19.7) | (13.9) | 14.7 |
| Continuing Operations | (19.7) | (13.9) | 14.7 |
| Discontinued Operations | 0.0 | 0.0 | 0.0 |
| Total Operations | (19.7) | (13.9) | 14.7 |
| Total Net Income | (19.7) | (13.9) | 14.7 |
| Net Profit Margin | -- | -- | 3.7% |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
